PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 29715146
OWN - NLM
STAT- MEDLINE
DCOM- 20180508
LR  - 20180508
IS  - 1791-7530 (Electronic)
IS  - 0250-7005 (Linking)
VI  - 38
IP  - 5
DP  - 2018 May
TI  - A Genitourinary Cancer-specific Scoring System for the Prediction of Survival in 
      Patients with Bone Metastasis: A Retrospective Analysis of Prostate Cancer, Renal
      Cell Carcinoma, and Urothelial Carcinoma.
PG  - 3097-3103
AB  - AIM: The aim of this study was to develop a risk scoring system specific to
      patients with bone metastasis of genitourinary cancer. MATERIALS AND METHODS:
      This study included 180 patients with bone metastasis of three major types of
      genitourinary cancer: prostate cancer (n=111), renal cell carcinoma (n=43,), and 
      urothelial carcinoma (n=26). Clinical factors at diagnosis of bone metastasis
      were evaluated to identify independent prognostic factors. RESULTS: Multivariate 
      analysis showed that type of primary cancer, poor performance status, the
      presence of visceral metastases, high Glasgow prognostic score and elevated
      neutrophil-to-lymphocyte ratio were independently predictive of poor prognosis.
      Patients were able to be classified by the prognostic risk score into four
      prognostic groups with low, intermediate, high, and very high risk. CONCLUSION:
      This risk scoring system could be useful for predicting survival of patients with
      bone metastasis of genitourinary cancer and in making decisions on appropriate
      treatments for them.
CI  - Copyright(c) 2018, International Institute of Anticancer Research (Dr. George J. 
      Delinasios), All rights reserved.
FAU - Owari, Takuya
AU  - Owari T
AD  - Department of Urology, Nara Medical University, Kashihara, Japan.
FAU - Miyake, Makito
AU  - Miyake M
AD  - Department of Urology, Nara Medical University, Kashihara, Japan
      [email protected]
FAU - Nakai, Yasushi
AU  - Nakai Y
AD  - Department of Urology, Nara Medical University, Kashihara, Japan.
FAU - Morizawa, Yosuke
AU  - Morizawa Y
AD  - Department of Urology, Nara Medical University, Kashihara, Japan.
FAU - Hori, Shunta
AU  - Hori S
AD  - Department of Urology, Nara Medical University, Kashihara, Japan.
FAU - Anai, Satoshi
AU  - Anai S
AD  - Department of Urology, Nara Medical University, Kashihara, Japan.
FAU - Tanaka, Nobumichi
AU  - Tanaka N
AD  - Department of Urology, Nara Medical University, Kashihara, Japan.
FAU - Fujimoto, Kiyohide
AU  - Fujimoto K
AD  - Department of Urology, Nara Medical University, Kashihara, Japan.
LA  - eng
PT  - Journal Article
PL  - Greece
TA  - Anticancer Res
JT  - Anticancer research
JID - 8102988
SB  - IM
MH  - Adult
MH  - Aged
MH  - Bone Neoplasms/classification/*mortality/*secondary
MH  - Carcinoma, Renal Cell/mortality/secondary
MH  - Carcinoma, Transitional Cell/mortality/secondary
MH  - Female
MH  - Humans
MH  - Kaplan-Meier Estimate
MH  - Kidney Neoplasms/mortality/secondary
MH  - Male
MH  - Middle Aged
MH  - Prognosis
MH  - Proportional Hazards Models
MH  - Prostatic Neoplasms/mortality/secondary
MH  - Retrospective Studies
MH  - Urinary Bladder Neoplasms/mortality/secondary
MH  - Urogenital Neoplasms/classification/*mortality/*secondary
OTO - NOTNLM
OT  - *Bone metastasis
OT  - *genitourinary cancer
OT  - *predicting survival
OT  - *prognostic factor
OT  - *scoring system
EDAT- 2018/05/02 06:00
MHDA- 2018/05/09 06:00
CRDT- 2018/05/02 06:00
PHST- 2018/02/24 00:00 [received]
PHST- 2018/03/29 00:00 [revised]
PHST- 2018/04/02 00:00 [accepted]
PHST- 2018/05/02 06:00 [entrez]
PHST- 2018/05/02 06:00 [pubmed]
PHST- 2018/05/09 06:00 [medline]
AID - 38/5/3097 [pii]
AID - 10.21873/anticanres.12568 [doi]
PST - ppublish
SO  - Anticancer Res. 2018 May;38(5):3097-3103. doi: 10.21873/anticanres.12568.